Determining the suitability of definitive radiation therapy in patients with metastatic nasopharyngeal carcinoma based on PET/CT: a large cohort study

[1]  O. Hoekstra,et al.  Not Yet Time to Abandon the Deauville Criteria in Diffuse Large B-Cell Lymphoma , 2021, The Journal of Nuclear Medicine.

[2]  S. Deng,et al.  Prognostic Value of 2-Deoxy-2-[18F]fluoro-D-glucose Positron Emission Tomography/Computed Tomography after Autologous Hematopoietic Stem Cell Transplantation in Lymphoma Using Deauville Scores , 2021, Contrast media & molecular imaging.

[3]  Weili Zhao,et al.  Deauville score evaluation of interim PET/CT in primary mediastinal large B-cell lymphoma , 2021, European Journal of Nuclear Medicine and Molecular Imaging.

[4]  S. Lim,et al.  The exact Deauville score, NABS score and high SUVmax predicts outcome in extranodal natural killer/T-cell lymphoma , 2021, Annals of Nuclear Medicine.

[5]  R. Boellaard,et al.  Interobserver Agreement on Automated Metabolic Tumor Volume Measurements of Deauville Score 4 and 5 Lesions at Interim 18F-FDG PET in Diffuse Large B-Cell Lymphoma , 2021, The Journal of Nuclear Medicine.

[6]  R. Sun,et al.  Nomogram for the prediction of primary distant metastasis of nasopharyngeal carcinoma to guide individualized application of FDG PET/CT , 2021, European Journal of Nuclear Medicine and Molecular Imaging.

[7]  N. Lee,et al.  Treatment Deescalation Strategies for Nasopharyngeal Cancer: A Review. , 2020, JAMA oncology.

[8]  P. Balermpas.  [Locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma significantly prolongs survival]. , 2020, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

[9]  R. Sun,et al.  Optimizing the Treatment Pattern for De Novo Metastatic Nasopharyngeal Carcinoma Patients: A Large-Scale Retrospective Cohort Study , 2020, Frontiers in Oncology.

[10]  M. Tan,et al.  Clinical utility of Epstein‐Barr virus DNA and other liquid biopsy markers in nasopharyngeal carcinoma , 2020, Cancer communications.

[11]  W. Xia,et al.  Development of a prognostic model to identify the suitable definitive radiotherapy candidates in de novo metastatic nasopharyngeal carcinoma: A real-world study. , 2020, International journal of radiation oncology, biology, physics.

[12]  M. Chua,et al.  Efficacy and Safety of Locoregional Radiotherapy With Chemotherapy vs Chemotherapy Alone in De Novo Metastatic Nasopharyngeal Carcinoma: A Multicenter Phase 3 Randomized Clinical Trial. , 2020, JAMA oncology.

[13]  Yingqin Li,et al.  A Gene-Expression Predictor for Efficacy of Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma. , 2020, Journal of the National Cancer Institute.

[14]  J. Shao,et al.  Risk stratification for nasopharyngeal carcinoma: a real-world study based on locoregional extension patterns and Epstein-Barr virus DNA load , 2020, Therapeutic advances in medical oncology.

[15]  H. Mai,et al.  Lymph-node Epstein–Barr virus concentration in diagnosing cervical lymph-node metastasis in nasopharyngeal carcinoma , 2020, European Archives of Oto-Rhino-Laryngology.

[16]  Li Lin,et al.  Prognostic potential of liquid biopsy tracking in the posttreatment surveillance of patients with nonmetastatic nasopharyngeal carcinoma , 2020, Cancer.

[17]  Yingqin Li,et al.  Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma. , 2019, The New England journal of medicine.

[18]  T. Werner,et al.  The Evolving Role of FDG-PET/CT in the Diagnosis, Staging, and Treatment of Breast Cancer , 2019, Molecular Imaging and Biology.

[19]  M. Meignan,et al.  Deauville score: the Phoenix rising from ashes , 2018, European Journal of Nuclear Medicine and Molecular Imaging.

[20]  Likun Chen,et al.  Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials. , 2018, The Lancet. Oncology.

[21]  P. Chevallier,et al.  A 4 or 5 Deauville score assessed by (18)F-FDG-PET CT early post-allotransplant is highly predictive of relapse in lymphoma patients. , 2018 .

[22]  Ya Cao,et al.  EBV based cancer prevention and therapy in nasopharyngeal carcinoma , 2017, npj Precision Oncology.

[23]  Kelly Y. Kim,et al.  Current State of PCR-Based Epstein-Barr Virus DNA Testing for Nasopharyngeal Cancer. , 2017, Journal of the National Cancer Institute.

[24]  Jianji Pan,et al.  Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial , 2016, The Lancet.

[25]  G. Eslick,et al.  Detecting Residual/Recurrent Head Neck Squamous Cell Carcinomas Using PET or PET/CT , 2016, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[26]  Per Nilsson,et al.  Qualitative interpretation of PET scans using a Likert scale to assess neck node response to radiotherapy in head and neck cancer , 2016, European Journal of Nuclear Medicine and Molecular Imaging.

[27]  Jun Ma,et al.  Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis. , 2015, The Lancet. Oncology.

[28]  Fenghua Wang,et al.  Prognostic factors in nasopharyngeal carcinoma with synchronous liver metastasis: a retrospective study for the management of treatment , 2013, Radiation oncology.

[29]  Li-Zhi Liu,et al.  Prospective study of tailoring whole-body dual-modality [18F]fluorodeoxyglucose positron emission tomography/computed tomography with plasma Epstein-Barr virus DNA for detecting distant metastasis in endemic nasopharyngeal carcinoma at initial staging. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  H. Tilly,et al.  An international confirmatory study of the prognostic value of early PET/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and ΔSUVmax , 2013, European Journal of Nuclear Medicine and Molecular Imaging.

[31]  Ji-An Liang,et al.  Accuracy of whole-body FDG-PET and FDG-PET/CT in M staging of nasopharyngeal carcinoma: a systematic review and meta-analysis. , 2013, European journal of radiology.

[32]  Wen-Qi Jiang,et al.  Comparison of five cisplatin-based regimens frequently used as the first-line protocols in metastatic nasopharyngeal carcinoma , 2012, Journal of Cancer Research and Clinical Oncology.

[33]  H. Boussen,et al.  Treatment for metastatic nasopharyngeal carcinoma. , 2011, European annals of otorhinolaryngology, head and neck diseases.

[34]  B. O'Sullivan,et al.  Factors contributing to the efficacy of concurrent-adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: combined analyses of NPC-9901 and NPC-9902 Trials. , 2011, European journal of cancer.

[35]  J. Bomanji,et al.  18F-FDG PET/CT Imaging In Oncology , 2011, Annals of Saudi medicine.

[36]  W. Oyen,et al.  FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0 , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[37]  Pelayo Vilar,et al.  Nasopharyngeal Carcinoma , 1966 .